Former genomics high flyer struggles to survive as a contract research organization... Gene Logic (GLGC) started out as a company that was going to solve the genomics puzzle. Armed with a novel gene expression readout platform, the so-called READS platform based on a proprietary flow-through chip and software to make “movies” of gene expression of all genes over time, the Company dazzled venture capitalists at it’s first Cold Spring Harbor presentation in the mid 90s. It quickly acquired database technology from Lawrence Berkeley National Laboratory and started a Data Logic subsidiary in Berkeley. The Company signed two significant R&D discovery deals, one with Proctor and Gamble and another with Japan Tobacco before going public in November of 1997. Then it all went wrong.
